Apixaget (Apixaban) is indicated for:
• The prevention of venous thromboembolic events (VTE) in adult patients who have undergone elective knee or hip replacement surgery.
• The prevention of stroke and systemic embolism in patients with atrial fibrillation.
KSh 80
Apixaget (Apixaban) is indicated for:
• The prevention of venous thromboembolic events (VTE) in adult patients who have undergone elective knee or hip replacement surgery.
• The prevention of stroke and systemic embolism in patients with atrial fibrillation.